| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/24/2003 | US20030138875 Method and apparatus for detecting the presence of microbes and determining their physiological status |
| 07/24/2003 | US20030138874 Method and kit for rapid concurrent identification and antimicrobial susceptibility testing of microorganisms from broth culture |
| 07/24/2003 | US20030138873 Tissue engineered cartilage for drug discovery |
| 07/24/2003 | US20030138872 Contacting a solution containing homocysteine and/or cystathionine with cystathionine beta-synthase, L-serine, cystathionine beta-lyase to catalyze cyclical conversion of homocysteine to cystathionine and then vice-versa conversion |
| 07/24/2003 | US20030138869 Identifying compounds/modulators that affect tubulin-like gtpase (FTSZ) activity during cell division; antiproliferative agents; microbiocides; bactericides; enzyme inhibitors |
| 07/24/2003 | US20030138867 Medium composition, method and device for selectively enhancing the isolation of anaerobic microorganisms contained in a mixed sample with facultative microorganisms |
| 07/24/2003 | US20030138865 Incubating LN3 cells expressing Peripheral-type benzodiazepine receptors (PBR)/(HRPC) with antitumor agents and monitoring tumor progression; antisense therapy; drug screening; antiandrogens |
| 07/24/2003 | US20030138864 Comparing expression levels of genes or proteins in human tissue or cells from normal and tumor origin, selecting enzyme of which mRNA or protein levels in tumor tissue are higher by two-fold as compared to normal cells or tissue |
| 07/24/2003 | US20030138856 Process for the measurement of dinophysistoxin and yessotoxin |
| 07/24/2003 | US20030138850 Selecting for antibody-antigen interactions in bacteria cells by employing a protein fragment complementation assay |
| 07/24/2003 | US20030138843 Generating/measuring improved polypeptide solubility in vitro/in situ using reporter molecule and mutagenesis |
| 07/24/2003 | US20030138842 Forming functionally organized, spatially patterned, alternating current mediated, self supporting, organic polymer-microparticle thin films/hydrogels |
| 07/24/2003 | US20030138839 Polypeptide comprising ubiquitination regulating domain; antiproliferative agents; neuroprotectants; cancer diagnosis |
| 07/24/2003 | US20030138838 Using nucleases and polymerases to determine gene expression profile during developmental processes, stress responses and disease states; forensics; restriction fragment length polymorphisms |
| 07/24/2003 | US20030138835 Tumor suppressors |
| 07/24/2003 | US20030138834 Detecting presence, location and identity of polymorphisms in DNA sequences with primer; fluorescence resonance energy transfer |
| 07/24/2003 | US20030138833 Psoriasin expression by breast epithelial cells |
| 07/24/2003 | US20030138832 Modulating insulin receptor signaling through targeting FACL |
| 07/24/2003 | US20030138831 Denaturing terminal monomer of nucleotide sequence and using single stranded RNA or DNA primers to determine sequence; improved polymerase chain reactions |
| 07/24/2003 | US20030138830 Parallel polymorphism scoring by amplification and error correction |
| 07/24/2003 | US20030138829 Comprises flow channels formed within an elastomeric material for use in thermocycling applications such as nucleic acid amplification, genotyping and gene expression analysis; high throughput assays |
| 07/24/2003 | US20030138828 Compositions and methods of selective nucleic acid isolation |
| 07/24/2003 | US20030138826 Compositions, methods, and kits relating to resistin-like molecules |
| 07/24/2003 | US20030138824 Method and kit for analyzing target nucleic acid fragment |
| 07/24/2003 | US20030138822 Polynucleotides and polypeptides, materials incorporating them and methods for using them |
| 07/24/2003 | US20030138821 System and method for temperature gradient capillary electrophoresis |
| 07/24/2003 | US20030138820 Sugar transport protein for use in diagnosis and treatment of diabetes, hypertriglyceridemia and hyperinsulinemia |
| 07/24/2003 | US20030138819 Method for detecting disease |
| 07/24/2003 | US20030138818 G-protein coupled receptors |
| 07/24/2003 | US20030138817 G protein coupled receptor protein, production, and use thereof |
| 07/24/2003 | US20030138816 Methods and kits for diagnosing the occurrence or the phase of minimal change nephrotic syndrome (MCNS) in a human |
| 07/24/2003 | US20030138815 Cyclic adenosine monophosphate (cAMP); drug screening; bronchodilators; antiinflammatory agents; immunomodulators; antiallergens; bioassays |
| 07/24/2003 | US20030138813 Method of diagnosis and disease risk assessment |
| 07/24/2003 | US20030138812 Monitoring mollusc, cyanobacterium and arthropod response and gene expression products (glutathione-s-transferase, superoxide dismutase, ubiquitin, and p-glycoprotein) in presence of heavy metals, herbicides and/or pesticides |
| 07/24/2003 | US20030138809 Sequencing DNA using polymerase, fluorescence, chemiluminescence, thermopile, thermistor and refractive index measurements; microcalorimetric detection |
| 07/24/2003 | US20030138807 Nucleotide sequences coding polypeptide associated with biosynthesis of glycans found as free oligosaccharides or bound to glycosphingolipids; treatment and prevention of infections; gene therapy; antiproliferative agents |
| 07/24/2003 | US20030138806 Classifying high quality rice using multiplex polymerase chain reaction |
| 07/24/2003 | US20030138803 Identification and use of molecules implicated in pain |
| 07/24/2003 | US20030138800 Replicating preferential nucleotide sequences using endonucleases and polymerases; nicking agent recognition sequence (NARS); nicking endonuclease recognition sequence (NERS) |
| 07/24/2003 | US20030138798 Detecting genetic mutation in fibrillin like (FBNL) genes and modulators associated with loss of central vision; vision correction treatments |
| 07/24/2003 | US20030138794 Using dimerized tags (DITAGS) to monitor sequencing accuracy associated with RNA and CDNA biosynthesis; serial analysis of gene expression (SAGE); differential gene expression (DGE) |
| 07/24/2003 | US20030138793 Kit for identifying the origin of tumors in prostate, breast, colorectal, lung, ovarian, gastroesophageal, pancreatic, liver, kidney or bladder cells by way of probes for analyzing marker gene expression |
| 07/24/2003 | US20030138792 Compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer |
| 07/24/2003 | US20030138790 Dynamic sequencing by hybridization |
| 07/24/2003 | US20030138789 Dynamic determination of analytes |
| 07/24/2003 | US20030138787 Comprising assay for distinguishing efficiency polymorphisms from inactivating mutations and silent polymorphisms; hereditary nonpolyposis colorectal cancer; tumor diagnosis |
| 07/24/2003 | US20030138785 Pteridinyl-based dimer catalyzes competitive bonding between fusion proteins (transglutaminases) on separate substrates, which activates expression of reporter gene (beta-lactamase) |
| 07/24/2003 | US20030138784 Linear and circular expression elements |
| 07/24/2003 | US20030138783 Aberrantly methylated genes as markers of breast malignancy |
| 07/24/2003 | US20030138782 Computer-directed assembly of a polynucleotide encoding a target polypeptide |
| 07/24/2003 | US20030138781 Monitoring patient response to glucocorticoids, estrogen or androgens; antiinflammatory agents; tumor necrosis factor; interleukins; cytokines; chemokines; interferons; c-reactive protein; vasoactive intestinal peptide; drug screening |
| 07/24/2003 | US20030138780 Investigating single fragment length polymorphisms (SNP) in nucleic acid sample; forensics; polymerase chain reactions; electrophoresis; colorimetric analysis |
| 07/24/2003 | US20030138779 Methods and devices for removal of organic molecules from biological mixtures using anion exchange |
| 07/24/2003 | US20030138778 Prediction of disease-causing alleles from sequence context |
| 07/24/2003 | US20030138777 Autonomous prototrophic/auxotrophic genetic system coding minimal gene set comprised of transcription, translation, aerobic metabolism, glycolysis/pyruvate dehydrogenase/pentose phosphate and nucleotide metabolism pathways |
| 07/24/2003 | US20030138773 Methods of transcriptionally modulating gene expression |
| 07/24/2003 | US20030138772 Polymerase chain reactions to screen and isolate parvovirus DNA obtained from tissue and/or cells without coinfection by helper viruses; gene therapy |
| 07/24/2003 | US20030138771 Detecting target (open reading frames) of bactericides/microbiocides; immunoaffinity chromatography/immunoprecipitation assay |
| 07/24/2003 | US20030138770 Detection and characterization of microorganisms |
| 07/24/2003 | US20030138767 Liquid interface configurations for automated patch clamp recording |
| 07/24/2003 | US20030138674 Interconversion of biochemical reducing power into electricity in a bioreactor of fuel cell by promoting cell growth, fermentation or enzyme transformation in the using neutral red; measuring oxygen demand for waste water |
| 07/24/2003 | US20030138475 Customer driven process of diagnosing and repairing vehicle involving providing customer with diagnostic tool that receives vehicle diagnostic signals from vehicle on-board computer, uploads signals from car, returns tool to service |
| 07/24/2003 | US20030138458 HCV E1E2 vaccine compositions |
| 07/24/2003 | US20030138442 Protein- or polynucleic acid-based vaccine which protects a pig against porcine reporductive and respiratory syndrome |
| 07/24/2003 | US20030138438 Compositions and methods for the therapy and diagnosis of lung cancer |
| 07/24/2003 | US20030138435 Gene encoding Cu/Zn superoxide dismutase, and cytotrophoblast express, after 3 days of culture, a peptide hormone selected from human placental lactogen, alpha or beta human chorionic gonadotrophin, human placental growth hormone and leptin |
| 07/24/2003 | US20030138431 Obtaining a biological sample from the patient, contacting the sample with a probe for LRRCAPS (leucin rich repeat, capricious releated gene) expression; c comparing result of contact with a control to determine the disease |
| 07/24/2003 | US20030138429 Compositions and methods for inhibiting metastasis |
| 07/24/2003 | US20030138414 Modulators of methylation for control of bacterial virulence |
| 07/24/2003 | US20030138406 Novel lactobacillus paracasei subsp. paracasei strain antibacterial against helicobacter pyroli and escherichia coli 0157:h7 |
| 07/24/2003 | US20030138377 Use of metabolic phenotyping in individualized treatment with amonafide |
| 07/24/2003 | US20030138363 Device for chemical and biochemical reactions using photo-generated reagents |
| 07/24/2003 | US20030138356 Distinguishing test types through spectral analysis |
| 07/24/2003 | US20030138208 Grating optical waveguide structure for multi-analyte determinations and the use thereof |
| 07/24/2003 | US20030136673 Amperometric sensors using synthetic substrates based on modeled active-site chemistry |
| 07/24/2003 | CA2765340A1 Novel calpastatin (cast) alleles |
| 07/24/2003 | CA2680946A1 Pim-3 kinase as a target for type 2 diabetes mellitus |
| 07/24/2003 | CA2477348A1 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling |
| 07/24/2003 | CA2474151A1 Androgen regulated nucleic acid molecules and encoded proteins |
| 07/24/2003 | CA2473613A1 Method for the quantification of in vivo nucleic acid levels |
| 07/24/2003 | CA2473434A1 Methods for making polynucleotides and purifying double-stranded polynucleotides |
| 07/24/2003 | CA2473299A1 Detection of a genetic predisposition to cancers and non-cancerous pathologies in mammals |
| 07/24/2003 | CA2473289A1 Asymmetric urea compounds useful as naaladase and psma imaging agents |
| 07/24/2003 | CA2473082A1 Verification of fish origin based on nucleic acid pattern recognition |
| 07/24/2003 | CA2472759A1 Gb virus b based replicons and replicon enhanced cells |
| 07/24/2003 | CA2472072A1 Means for identifying neisseiria menengitidis specific genes |
| 07/24/2003 | CA2472016A1 Method and device for identifying substances capable of modulating adipicyte differentiation |
| 07/24/2003 | CA2471744A1 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 07/24/2003 | CA2471513A1 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease |
| 07/24/2003 | CA2471480A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | CA2471473A1 High fidelity dna polymerase compositions and uses therefor |
| 07/24/2003 | CA2471223A1 Method for analyzing effects of medical agents |
| 07/24/2003 | CA2471218A1 Heteroconfigurational polynucleotide and methods of use |
| 07/24/2003 | CA2470460A1 Fusarium head blight resistance qtls in wheat |
| 07/24/2003 | CA2470421A1 Use of a novel cell surface protease from group b streptococcus |
| 07/24/2003 | CA2470359A1 Assay for the detection of factors that modulate the expression of ingap |
| 07/24/2003 | CA2469472A1 Endothelial stem cells, populations, methods of isolation and use thereof |
| 07/24/2003 | CA2465178A1 Adapter-directed display system |
| 07/24/2003 | CA2464131A1 Compositions and methods for controlled release |
| 07/24/2003 | CA2438106A1 Rapid method of selecting cells for gene disruption by homologous recombination |